Skip to content

Do CD4 counts rise less on abacavir or nevirapine-based HAART?

Atazanavir begins to lose its clout as protease mutations rise

Combination of indinavir/AZT/3TC still effective for majority of patients at 6 years, says US study

Induction/maintenance approach revived – but will patients stick with it?

Herpes and genital warts most common symptoms of immune reconstitution inflammatory syndrome (IRIS)

Barebacking the sole common risk factor in London's sexually transmitted hepatitis C epidemic

Suboptimal drug levels more common with nevirapine than efavirenz

Four NHS staff have died after contracting HIV from needle accidents, says MP's report

Prevalence of drug resistant HIV in the UK on the rise